FDA Approved: CILOSTAZOL — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approval of a supplemental application for cilostazol from Apotex Corp., enabling continued generic supply under the approved scope.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Intermittent Claudication
• Peripheral Artery Disease

Drugs mentioned

• Cilostazol (Cilostazol)

Snippet

SUPPL AP for CILOSTAZOL (CILOSTAZOL)